AIPT - Precision Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue654.836456.495654.354
Cost of Revenue148.045181.62303.982
Gross Profit506.791274.875350.372
Operating Expenses
Research Development---
Selling General and Administrative8,253.3846,800.8864,750.015
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-7,746.593-6,526.011-4,399.643
Income from Continuing Operations
Total Other Income/Expenses Net---
Earnings Before Interest and Taxes-7,746.593-6,526.011-4,399.643
Interest Expense-0.003390.887
Income Before Tax-7,746.593-6,526.014-4,790.53
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-7,746.593-6,526.014-4,790.53
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,746.593-6,526.014-4,790.53
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,746.593-6,526.014-4,790.53